Fig. 6: miR-450b-5p/CRYAB transformed M2 polarization.
From: Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB
a, b, d Protein expression of Arg-1, TGF-β1, and Akt/mTOR pathway. c mRNA levels of CD206, Arg-1, and TGF-β after inhibition of miR-450b-5p or CRYAB by miR-450b-5p inhibitors or CRYAB shRNA. e, f Immunofluorescence of Arg-1 and CD206. Scale bar = 50 μm. *P < 0.05, **P < 0.01, nsP > 0.05.
